| In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo L Tona, RK Cimanga, K Mesia, CT Musuamba, T De Bruyne, S Apers, ... Journal of ethnopharmacology 93 (1), 27-32, 2004 | 434 | 2004 |
| Pharmacokinetics and dosage adjustment in patients with renal dysfunction RK Verbeeck, FT Musuamba European journal of clinical pharmacology 65, 757-773, 2009 | 357 | 2009 |
| In silico clinical trials: concepts and early adoptions F Pappalardo, G Russo, FM Tshinanu, M Viceconti Briefings in bioinformatics 20 (5), 1699-1708, 2019 | 198 | 2019 |
| In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products M Viceconti, F Pappalardo, B Rodriguez, M Horner, J Bischoff, ... Methods 185, 120-127, 2021 | 181 | 2021 |
| Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study F Frippiat, FT Musuamba, L Seidel, A Albert, R Denooz, C Charlier, ... Journal of Antimicrobial Chemotherapy 70 (1), 207-216, 2015 | 78 | 2015 |
| General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy Z Li, GR Mirams, T Yoshinaga, BJ Ridder, X Han, JE Chen, ... Clinical Pharmacology & Therapeutics 107 (1), 102-111, 2020 | 74 | 2020 |
| Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients IK Delattre, FT Musuamba, J Nyberg, FS Taccone, PF Laterre, ... Therapeutic drug monitoring 32 (6), 749-756, 2010 | 71 | 2010 |
| Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells A Capron, F Musuamba, D Latinne, M Mourad, J Lerut, V Haufroid, ... Therapeutic drug monitoring 31 (2), 178-186, 2009 | 70 | 2009 |
| Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus FT Musuamba, A Rousseau, JL Bosmans, JJ Senessael, J Cumps, ... Clinical pharmacokinetics 48, 745-758, 2009 | 68 | 2009 |
| Advanced methods for dose and regimen finding during drug development: summary of the EMA/EFPIA workshop on dose finding (London 4–5 December 2014) FT Musuamba, E Manolis, N Holford, SYA Cheung, LE Friberg, ... CPT: pharmacometrics & systems pharmacology 6 (7), 418-429, 2017 | 65 | 2017 |
| In vitro antiplasmodial activity of callus culture extracts and fractions from fresh apical stems of Phyllanthus niruri L.(Euphorbiaceae): part 2 RK Cimanga, L Tona, N Luyindula, K Mesia, M Lusakibanza, ... Journal of ethnopharmacology 95 (2-3), 399-404, 2004 | 64 | 2004 |
| In vitro antiplasmodial activity of callus culture extracts and fractions from fresh apical stems of Phyllanthus niruri L. (Euphorbiaceae): part 2. VAJ Cimanga RK, Tona L, Luyindula N, Mesia K, Lusakibanza M, Musuamba CT ... J Ethnopharmacol., 399-404, 2004 | 64 | 2004 |
| Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility FT Musuamba, I Skottheim Rusten, R Lesage, G Russo, R Bursi, L Emili, ... CPT: Pharmacometrics & Systems Pharmacology 10 (8), 804-825, 2021 | 61 | 2021 |
| A simultaneous d‐optimal designed study for population pharmacokinetic analyses of mycophenolic acid and tacrolimus early after renal transplantation FT Musuamba, M Mourad, V Haufroid, M Demeyer, A Capron, IK Delattre, ... The Journal of Clinical Pharmacology 52 (12), 1833-1843, 2012 | 54 | 2012 |
| The revised 2010 EMA guideline for the investigation of bioequivalence for immediate release oral formulations with systemic action RK Verbeeck, FM Tshinanu Journal of Pharmacy and Pharmaceutical Sciences 15 (3), 376-388, 2012 | 51 | 2012 |
| Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study FT Musuamba, M Mourad, V Haufroid, IK Delattre, RK Verbeeck, ... Therapeutic drug monitoring 31 (6), 734-742, 2009 | 48 | 2009 |
| Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation? A Buemi, F Musuamba, S Frederic, A Douhet, M De Meyer, L De Pauw, ... Clinical biochemistry 47 (15), 68-72, 2014 | 46 | 2014 |
| Prediction of paraquat exposure and toxicity in clinically ill poisoned patients: a model based approach K Wunnapuk, F Mohammed, I Gawarammana, X Liu, RK Verbeeck, ... British Journal of Clinical Pharmacology 78 (4), 855-866, 2014 | 45 | 2014 |
| Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin IK Delattre, FT Musuamba, P Jacqmin, FS Taccone, PF Laterre, ... Clinical biochemistry 45 (10-11), 780-786, 2012 | 43 | 2012 |
| Antimalarial efficacy of a quantified extract of Nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 2: a clinical … K Mesia, L Tona, MM Mampunza, N Ntamabyaliro, T Muanda, T Muyembe, ... Planta medica 78 (09), 853-860, 2012 | 41 | 2012 |
